Literature DB >> 22144632

Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.

John F Carlquist1, Jeffrey L Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144632     DOI: 10.1161/CIRCULATIONAHA.111.019737

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

Review 2.  Therapeutic drug monitoring for tomorrow.

Authors:  Erik Eliasson; Jonatan D Lindh; Rickard E Malmström; Olof Beck; Marja-Liisa Dahl
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

3.  Drug-gene interactions: inherent variability in drug maintenance dose requirements.

Authors:  Paul Westervelt; Kihoon Cho; David R Bright; David F Kisor
Journal:  P T       Date:  2014-09

Review 4.  Cardiovascular drugs and the genetic response.

Authors:  Sonny Dandona
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 5.  Diet-gene interactions underlie metabolic individuality and influence brain development: implications for clinical practice derived from studies on choline metabolism.

Authors:  Steven H Zeisel
Journal:  Ann Nutr Metab       Date:  2012-05-15       Impact factor: 3.374

6.  VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.

Authors:  Fatima Donia Mili; Tenecia Allen; Paula Weinstein Wadell; W Craig Hooper; Christine De Staercke; Christopher J Bean; Cathy Lally; Harland Austin; Nanette K Wenger
Journal:  Future Cardiol       Date:  2017-12-08

Review 7.  Genomics in cardiovascular disease.

Authors:  Robert Roberts; A J Marian; Sonny Dandona; Alexandre F R Stewart
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

Review 8.  Warfarin pharmacogenetics: does more accurate dosing benefit patients?

Authors:  Charles Eby
Journal:  Semin Thromb Hemost       Date:  2012-10-09       Impact factor: 4.180

Review 9.  Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.

Authors:  Erik Fung; Nikolaos A Patsopoulos; Steven M Belknap; Daniel J O'Rourke; John F Robb; Jeffrey L Anderson; Nicholas W Shworak; Jason H Moore
Journal:  Semin Thromb Hemost       Date:  2012-10-06       Impact factor: 4.180

10.  Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.

Authors:  Valentin Fuster; Deepak L Bhatt; Robert M Califf; Alan D Michelson; Marc S Sabatine; Dominick J Angiolillo; Eric R Bates; David J Cohen; Barry S Coller; Bruce Furie; Jean-Sebastien Hulot; Kenneth G Mann; Jessica L Mega; Kiran Musunuru; Christopher J O'Donnell; Matthew J Price; David J Schneider; Daniel I Simon; Jeffrey I Weitz; Marlene S Williams; W Keith Hoots; Yves D Rosenberg; Ahmed A K Hasan
Journal:  Circulation       Date:  2012-09-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.